Yili Chuanning Biotechnology Co.,Ltd. (SHE:301301)
China · Delayed Price · Currency is CNY 8.18
-0.34 (-3.99%)
At close: Sep 11, 2026
SHE:301301 Market Cap
SHE:301301 has a market cap or net worth of 19.02 billion as of September 11, 2026. Its market cap has decreased by -25.71% in one year.
Market Cap
19.02B
Enterprise Value
19.40B
Revenue
4.37B
Ranking
n/a
PE Ratio
32.85
Stock Price
8.18
ChartMarket Cap Chart
Since December 27, 2022, SHE:301301's market cap has decreased from 22.34B to 19.02B, a decrease of -14.86%. That is a compound annual growth rate of -4.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 18.26B | -19.25% |
| Dec 31, 2025 | 22.61B | -14.39% |
| Dec 31, 2024 | 26.41B | 41.47% |
| Dec 29, 2023 | 18.67B | -6.15% |
| Dec 30, 2022 | 19.89B | -10.95% |
| Dec 27, 2022 | 22.34B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Beijing Tiantan Biological Products | 25.17B |
| Hualan Biological Engineering | 24.35B |
| Xiamen Amoytop Biotech | 22.70B |
| Hebei Changshan Biochemical Pharmaceutical | 21.62B |
| BrightGene Bio-Medical Technology | 16.50B |
| Sinocelltech Group | 16.17B |
| Acrobiosystems | 15.46B |
| Anhui Anke Biotechnology (Group) | 13.97B |